newsfilter
← Latest News
Business Wire·

Magellan Rx Management Oncology Biosimilar Solution Delivers $40M+ in Annualized Savings for Early Adopter Health Plans

Health plans who adopted the program have experienced over 20% savings by switching to lower-cost biosimilars The proprietary prior authorization process integrates seamlessly, limiting disruption within the provider network while maintaining high